Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical Other Non-Current Liabilities 2010-2024 | TAK

Takeda Pharmaceutical other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Takeda Pharmaceutical other non-current liabilities for the quarter ending September 30, 2024 were $4.588B, a 0.63% decline year-over-year.
  • Takeda Pharmaceutical other non-current liabilities for 2024 were $5.434B, a 7.96% increase from 2023.
  • Takeda Pharmaceutical other non-current liabilities for 2023 were $5.033B, a 7.29% decline from 2022.
  • Takeda Pharmaceutical other non-current liabilities for 2022 were $5.429B, a 10.74% decline from 2021.
  
Takeda Pharmaceutical Annual Other Non-Current Liabilities
(Millions of US $)
2024 $5,434
2023 $5,033
2022 $5,429
2021 $6,082
2020 $5,009
2019 $3,674
2018 $1,688
2017 $1,812
2016 $1,723
2015 $1,783
2014 $1,641
2013 $2,910
2012 $1,699
2011 $1,018
2010 $783
2009 $763
Takeda Pharmaceutical Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-06-30 $4,588
2024-03-31 $5,434
2023-12-31 $4,300
2023-09-30 $4,590
2023-06-30 $4,617
2023-03-31 $5,033
2022-12-31 $4,651
2022-09-30 $5,135
2022-06-30 $5,118
2022-03-31 $5,429
2021-12-31 $5,254
2021-09-30 $5,357
2021-06-30 $5,645
2021-03-31 $6,082
2020-12-31 $6,038
2020-09-30 $5,683
2020-06-30 $5,080
2020-03-31 $5,009
2019-12-31 $5,192
2019-09-30 $5,204
2019-06-30 $5,182
2018-12-31 $2,081
2018-06-30 $1,628
2017-06-30 $1,692
2016-06-30 $1,800
2015-06-30 $1,624
2015-03-31 $2,618
2014-12-31 $2,329
2014-09-30 $2,695
2014-06-30 $2,622
2014-03-31 $2,406
2013-12-31 $2,614
2013-09-30 $2,512
2013-06-30 $2,456
2013-03-31 $2,910
2012-12-31 $2,805
2012-09-30 $2,454
2012-06-30 $2,355
2012-03-31 $1,699
2011-12-31 $1,839
2011-09-30 $1,855
2011-03-31 $1,018
2010-03-31 $783
2009-09-30
2009-03-31 $763
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $41.396B $28.196B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.775B 28.39
Chugai Pharmaceutical (CHGCY) Japan $70.198B 27.35
Merck (MKKGY) Germany $18.461B 16.53
Sandoz Group AG (SDZNY) Switzerland $18.159B 0.00
Astellas Pharma (ALPMY) Japan $17.463B 16.08
United Therapeutics (UTHR) United States $16.079B 15.82
Neurocrine Biosciences (NBIX) United States $13.664B 36.18
Summit Therapeutics (SMMT) United States $13.569B 0.00
Shionogi (SGIOY) Japan $11.688B 11.71
Madrigal Pharmaceuticals (MDGL) United States $6.399B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.620B 0.00
Corcept Therapeutics (CORT) United States $5.359B 40.60
Crinetics Pharmaceuticals (CRNX) United States $4.891B 0.00
PTC Therapeutics (PTCT) United States $3.490B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.560B 11.60
Dyne Therapeutics (DYN) United States $2.473B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.401B 14.35
NewAmsterdam Pharma (NAMS) Netherlands $2.352B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.314B 0.00
Soleno Therapeutics (SLNO) United States $1.949B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.746B 0.00
Xencor (XNCR) United States $1.680B 0.00
Indivior (INDV) United States $1.591B 6.48
Evotec AG (EVO) Germany $1.559B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.531B 0.00
Guardian Pharmacy Services (GRDN) United States $1.382B 0.00
Ocular Therapeutix (OCUL) United States $1.328B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.294B 0.00
Harrow (HROW) United States $1.226B 0.00
Enliven Therapeutics (ELVN) United States $1.117B 0.00
Ardelyx (ARDX) United States $1.111B 0.00
ARS Pharmaceuticals (SPRY) United States $1.100B 0.00
Collegium Pharmaceutical (COLL) United States $0.982B 5.36
Avadel Pharmaceuticals (AVDL) Ireland $0.974B 0.00
Bioventus (BVS) United States $0.854B 26.97
Oruka Therapeutics (ORKA) United States $0.727B 0.00
Cronos Group (CRON) Canada $0.715B 0.00
Relay Therapeutics (RLAY) United States $0.713B 0.00
USANA Health Sciences (USNA) United States $0.662B 12.27
Ironwood Pharmaceuticals (IRWD) United States $0.621B 0.00
Elite Pharmaceuticals (ELTP) United States $0.609B 0.00
Altimmune (ALT) United States $0.582B 0.00
Savara (SVRA) United States $0.554B 0.00
Tourmaline Bio (TRML) United States $0.522B 0.00
Xeris Biopharma Holdings (XERS) United States $0.508B 0.00
OmniAb (OABI) United States $0.494B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.478B 0.00
Zevra Therapeutics (ZVRA) United States $0.456B 0.00
Verve Therapeutics (VERV) United States $0.437B 0.00
Siga Technologies (SIGA) United States $0.431B 5.03
Esperion Therapeutics (ESPR) United States $0.429B 0.00
ProKidney (PROK) United States $0.426B 0.00
Organogenesis (ORGO) United States $0.412B 0.00
Korro Bio (KRRO) United States $0.404B 0.00
KalVista Pharmaceuticals (KALV) United States $0.400B 0.00
Akebia Therapeutics (AKBA) United States $0.391B 0.00
Aquestive Therapeutics (AQST) United States $0.332B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.303B 122.93
Avita Medical (RCEL) United States $0.301B 0.00
Aldeyra Therapeutics (ALDX) United States $0.289B 0.00
Nature's Sunshine Products (NATR) United States $0.280B 16.63
Amylyx Pharmaceuticals (AMLX) United States $0.271B 0.00
4D Molecular Therapeutics (FDMT) United States $0.267B 0.00
Larimar Therapeutics (LRMR) United States $0.254B 0.00
Heron Therapeutics (HRTX) United States $0.233B 0.00
Innate Pharma SA (IPHYF) France $0.233B 0.00
Profound Medical (PROF) Canada $0.219B 0.00
Inhibikase Therapeutics (IKT) United States $0.212B 0.00
Acrivon Therapeutics (ACRV) United States $0.208B 0.00
Lexeo Therapeutics (LXEO) United States $0.200B 0.00
Aclaris Therapeutics (ACRS) United States $0.198B 0.00
Silence Therapeutics (SLN) United Kingdom $0.190B 0.00
Lyell Immunopharma (LYEL) United States $0.187B 0.00
MediWound (MDWD) Israel $0.186B 0.00
Nektar Therapeutics (NKTR) United States $0.174B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.162B 0.00
Nanobiotix S.A (NBTX) France $0.155B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Metagenomi (MGX) United States $0.144B 0.00
VAXART, INC (VXRT) United States $0.137B 0.00
Telomir Pharmaceuticals (TELO) United States $0.134B 0.00
Achieve Life Sciences (ACHV) Canada $0.131B 0.00
Galectin Therapeutics (GALT) United States $0.126B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Cassava Sciences (SAVA) United States $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Protara Therapeutics (TARA) United States $0.107B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.107B 0.00
Champions Oncology (CSBR) United States $0.104B 0.00
Regulus Therapeutics (RGLS) United States $0.102B 0.00
Inotiv (NOTV) United States $0.100B 0.00
Journey Medical (DERM) United States $0.097B 0.00
ElectroCore (ECOR) United States $0.095B 0.00
Avalo Therapeutics (AVTX) United States $0.094B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Century Therapeutics (IPSC) United States $0.089B 0.00
Fractyl Health (GUTS) United States $0.088B 0.00
Karyopharm Therapeutics (KPTI) United States $0.082B 0.00
Context Therapeutics (CNTX) United States $0.082B 0.00
Assertio Holdings (ASRT) United States $0.080B 21.08
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Unicycive Therapeutics (UNCY) United States $0.074B 0.00
ESSA Pharma (EPIX) Canada $0.071B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Scienture Holdings (SCNX) United States $0.070B 0.00
OptiNose (OPTN) United States $0.064B 0.00
Mural Oncology (MURA) Ireland $0.053B 0.00
AlloVir (ALVR) United States $0.052B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Iterum Therapeutics (ITRM) Ireland $0.048B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
Gain Therapeutics (GANX) United States $0.042B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
BioVie (BIVI) United States $0.037B 0.00
FibroGen (FGEN) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.031B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
DURECT (DRRX) United States $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
MEI Pharma (MEIP) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Dominari Holdings (DOMH) United States $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
CERo Therapeutics Holdings (CERO) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Conduit Pharmaceuticals (CDT) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Biomerica (BMRA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
SHINECO (SISI) China $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
Jupiter Neurosciences (JUNS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.69
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 41.84